scholarly journals SURGICAL TREATMENT FOR CARDIAC MYXOMAS-A REVIEW OF 13 CASES-

1997 ◽  
Vol 58 (5) ◽  
pp. 960-963
Author(s):  
Seiji KINUGASA ◽  
Shinjiro SASAKI ◽  
Hiroshi IRIE ◽  
Nanritsu MATSUYAMA ◽  
Junko OKAMOTO ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Cardiac Myxomas

scholarly journals Cardiac myxoma: The influence of preoperative clinical presentation and surgical technique on late outcome

2007 ◽  
Vol 135 (7-8) ◽  
pp. 401-406
Author(s):  
Aleksandar Mikic ◽  
Biljana Obrenovic-Kircanski ◽  
Mladen Kocica ◽  
Mile Vranes ◽  
Vesna Lackovic ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Clinical Presentation ◽  
Cardiac Myxoma ◽  
Surgical Techniques ◽  
Right Atrial ◽  
Functional Improvement ◽  
Primary Tumors ◽  
Cardiac Myxomas ◽  
The Right

Introduction Cardiac myxomas are the most frequent primary tumors of the heart in adults, and they can be found in each of four cardiac chambers. Although biologically benign, due to their unfavorable localization, myxomas are considered "functionally malignant" tumors. Diagnosis of cardiac myxoma necessitates surgical treatment. Objective To analyze: 1) the influence of localization, size and consistency of cardiac myxomas on preoperative symptomatology; 2) the influence of different surgical techniques (left, right, biatrial approach, tumor basis solving) on early, and late outcomes. Method From 1982 to 2000, at the Institute for Cardiovascular Diseases, Clinical Center of Serbia, there were 46 patients with cardiac myxomas operated on, 67.4% of them women, mean age 47.1?16.3 years. The diagnosis was made according to clinical presentation, electrocardiographic and echocardiographic examinations and cardiac catheterization. Follow-up period was 4-18 (mean 7.8) years. Results In 41 (89.1%) patients, myxoma was localized in the left, while in 5 (10.9%), it was found in the right atrium. Average size was 5.8?3.8 cm (range: 1?1 cm to 9?8 cm) and 6?4 cm (range: 3?2 cm to 9?5 cm) for the left and right atrial myxomas, respectively. A racemous form predominated in the left (82.6%) and globous in the right (80%) atrium. Fatigue was the most common general (84.8%) and dyspnoea the most common cardiologic symptom (73.9%). Preoperative embolic events were present in 8 patients (4 pulmonary, 4 systemic). In our series: 1) different localization, size and consistency had no influence on the preoperative symptomatology; 2) surgical treatment applied, regardless of different approaches and basis solving, resulted in excellent functional improvements (63.1% patients in NYHA III and IV class preoperatively vs. 6.7% patients postoperatively) and had no influence on new postoperative rhythm disturbances (8.7% patients preoperatively vs. 24.4% patients postoperatively); 3) early (97.8%), and late survival rates (91.3%) were excellent; 4) there were no relapses during the follow-up period. Conclusion Localization, size and consistency had no influence on the preoperative symptomatology. Excellent survival rate with significant functional improvement, rare postoperative complications and no recurrences, justify the applied strategies of surgical approach and tumor basis solving in our series.

The Variations in the Immunologic Features and Interleukin-6 Levels for the Surgical Treatment of Cardiac Myxomas

Surgery Today ◽  
2007 ◽  
Vol 37 (9) ◽  
pp. 750-753 ◽  
Author(s):  
Hiroki Yokomuro ◽  
Katsunori Yoshihara ◽  
Yoshinori Watanabe ◽  
Noritsugu Shiono ◽  
Nobuya Koyama ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Interleukin 6 ◽  
Cardiac Myxomas

Surgical treatment of cardiac myxomas: Longterm results

1990 ◽  
Vol 50 (4) ◽  
pp. 557-561 ◽  
Author(s):  
Frank W. Sellke ◽  
John H. Lemmer ◽  
Byron F. Vandenberg ◽  
Johann L. Ehrenhaft
Keyword(s):  
Surgical Treatment ◽  
Longterm Results ◽  
Cardiac Myxomas

scholarly journals Cardiac masses due to tumors (diagnosis, clinical manifestations and surgical treatment)

2014 ◽  
Vol 95 (6) ◽  
pp. 806-810 ◽  
Author(s):  
D L Kranin
Keyword(s):  
Surgical Treatment ◽  
Malignant Tumors ◽  
Clinical Manifestations ◽  
Surgical Excision ◽  
Benign Tumors ◽  
Cardiac Tumors ◽  
Low Grade ◽  
Imaging Results ◽  
Valvular Heart Diseases ◽  
Cardiac Myxomas

Aim. To summarize the experience on the diagnosis and surgical treatment of primary benign and malignant cardiac tumors. Methods. The paper describes 37 clinical observations of endocavitary primary benign and malignant cardiac tumors: 26 (70.3%) cases of cardiac myxoma, 5 (13.5%) - rhabdomyosarcoma, 2 (5.4%) - angiosarcoma, 1 (2.7% ) - leiomyosarcoma, 1 (2.7%) - fibrosarcoma, 1 (2.7%) - liposarcoma. Patients were 15 (40.5%) males and 22 (59.5%) females aged 18 to 65 years. Endocavitary cardiac tumors were diagnosed by noninvasive tests: echocardiography, computed tomography, magnetic resonance imaging. Results. Patients with primary benign and malignant cardiac tumors had variable clinical manifestations. Symptoms of astenoneurotic syndrome, auscultatory and cardiophonographic signs simulating acquired or congenital valvular heart diseases, which often have a positional relationship; low-grade fever of unknown origin, weight loss were registered. Paraneoplastic syndrome was characterized by an increase in erythrocyte sedimentation rate, leukocytosis, monocytosis, dysproteinemia, polycythemia, hypochromic anemia, increased levels of C-reactive protein. Surgical excision of 25 cardiac myxomas and 8 malignant tumors of the heart was performed with cardiopulmonary bypass, pharmacological cardioplegia and general hypothermia. In 1 case the tumor resection was combined with coronary artery bypass grafting. In 3 patients suffering from malignant tumors, explorative thoracotomy was performed. Surgical revision, emergency and planned microscopic studies of removed cardiac tumors allowed to establish the final clinical diagnosis. Hospital mortality among patients operated for cardiac myxomas was 4.0%, for cardiac malignant tumors - 27.3%. Conclusion. Timely surgical treatment of patients with primary cardiac benign tumors (myxomas) leads to recovery and is accompanied by a relatively low mortality; better results of patients with cardiac endocavitary tumors treatment depend on the early detection and timely radical surgical excision.

scholarly journals Surgical treatment of cardiac myxomas

1988 ◽  
Vol 96 (5) ◽  
pp. 800-805 ◽  
Author(s):  
V.I. Burakovsky ◽  
G.I. Zuckerman ◽  
G.A. Kossatch ◽  
M.A. Golossovskaya ◽  
L.A. Javorskaya
Keyword(s):  
Surgical Treatment ◽  
Cardiac Myxomas

scholarly journals Cardiac Myxomas: A single center experience and ten-years follow up

2019 ◽  
Vol 1 (2) ◽  
pp. 40-48
Author(s):  
Essam Elbadry Hashim Mohamed ◽  
Ayman Mohamed Mohamed Abdel Ghaffar ◽  
Khaled Mohamed Abdelaal ◽  
Abdelrahman Adel Abdelaziz Elsayed ◽  
Mohamed AW Ezzat ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Surgical Approach ◽  
Postoperative Bleeding ◽  
Cardiac Myxoma ◽  
Surgical Excision ◽  
Right Atrial ◽  
Tricuspid Valve Repair ◽  
Supraventricular Arrhythmia ◽  
Pulmonary Atelectasis ◽  
Cardiac Myxomas

Background: Cardiac myxoma is a benign tumor that carries the risk of embolization and obstruction of the blood flow. The ideal surgical approach is still debatable. We present our experience in the surgical treatment of cardiac myxomas and its ideal surgical approach.Methods: We retrospectively analyzed the data for all patients who underwent surgical excision of cardiac myxoma at our institution over 11 years starting from January 2006 to December 2016. Descriptive statistics were used to present preoperative, operative and postoperative data and Kaplan Meier curve to plot long-term survival.Results: Twenty-one patients had surgical excision of a primary, single and sporadic cardiac myxoma. Thirteen patients (62 %) were females, and the mean age at operation was 55.2 years (range: 28 – 71 years). The location of myxomas was in the left atrium in 17 patients (81%) and right atrium in 4 patients (19 %). Dyspnea was the main presenting symptom (71.4%) followed by constitutional symptoms (28%), palpitations (23.8%), syncope (14.2%) and stroke (14.2%). A right atrial trans-septal incision was used in 76.5% of left atrial myxoma cases. Five patients had concomitant operative procedures (coronary artery bypass grafting (n=2), tricuspid valve repair (n=1), mitral valve replacement (n=1) and bullectomy (n=1)). Postoperative complications were reported in six patients (28.6%) (supraventricular arrhythmia (n=2), temporary conduction deficit (n=2), pulmonary atelectasis (n=1), and postoperative bleeding (n=1)). Early postoperative mortality occurred in one patient (4.76 %), and there were no late deaths related to myxoma.Conclusion: Surgical treatment of cardiac myxoma is safe with low morbidity and mortality. The right atrial trans-septal incision is the recommended surgical approach.

scholarly journals Surgical Treatment for Cardiac Myxomas. 20 Years' Experience in Consecutive 17 Cases.

2000 ◽  
Vol 29 (3) ◽  
pp. 144-148
Author(s):  
Mitsuhiro Yamamura ◽  
Takashi Miyamoto ◽  
Katsuhiko Yamashita ◽  
Hideki Yao ◽  
Kazushige Inoue ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Cardiac Myxomas
Sign in / Sign up

Export Citation Format

Share Document